Acute tonsillopharyngitis associated with atypical bacterial infection in children: Natural history and impact of macrolide therapy

Clinical Infectious Diseases

Volumn 43, Issue 2, 2006, Pages 206-209

  Esposito, Susanna ^a   Bosis, Samantha ^a   Begliatti, Enrica ^a   Droghetti, Roberta ^a   Tremolati, Elena ^a   Tagliabue, Claudia ^a   Bellasio, Marta ^a   Blasi, Francesco ^a   Principi, Nicola ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; BACTERIAL DNA; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INFLUENZA VACCINE; MACROLIDE; PARACETAMOL; PNEUMOCOCCUS VACCINE;

ACUTE DISEASE; ADOLESCENT; ANTIBIOTIC THERAPY; ANTIBODY TITER; BACTERIAL INFECTION; CHILD; CHILD HOSPITALIZATION; CHLAMYDOPHILA PNEUMONIAE; DRUG TREATMENT FAILURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; INFANT; INFLUENZA; MAJOR CLINICAL STUDY; MALE; MYCOPLASMA PNEUMONIAE; PHARYNGITIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; SEROLOGY; TONSILLITIS; TREATMENT OUTCOME;

ACUTE DISEASE; ADOLESCENT; ANTI-BACTERIAL AGENTS; ANTIBODIES, BACTERIAL; AZITHROMYCIN; CHILD; CHILD, PRESCHOOL; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; DISEASE PROGRESSION; FEMALE; HUMANS; INFANT; MALE; MYCOPLASMA INFECTIONS; MYCOPLASMA PNEUMONIAE; PHARYNGEAL DISEASES; PHARYNGITIS; RECURRENCE; TONSILLITIS; TREATMENT OUTCOME;

EID: 33745728390     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/505120     Document Type: Review

References (12)

1. Bisno AL. Primary care: acute pharyngitis. N Engl J Med 2001; 344:205-11.
2. Bisno AL, Gerber MA, Gwaltney JM Jr, Kaplan EL, Schwartz RH. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Clin Infect Dis 2002; 35:113-25.
3. Esposito S, Cavagna R, Bosis S, Droghetti R, Faelli N, Principi N. Emerging role of Mycoplasma pneumoniae in children with acute pharyngitis. Eur J Clin Microbiol Infect Dis 2002; 21:607-10.
4. Esposito S, Blasi F, Bosis S, et al. Aetiology of acute pharyngitis: the role of atypical bacteria. J Med Microbiol 2004; 53:645-51.
5. Principi N, Esposito S. Emerging role of Mycoplasma pneumoniae and Chlamydia pneumoniae in paediatric respiratory tract infections. Lancet Infect Dis 2001; 1:334-44.
6. Biscardi S, Lorrot M, Marc E, et al. Mycoplasma pneumoniae and asthma in children. Clin Infect Dis 2004; 38:1341-6.
7. Esposito S, Bosis S, Cavagna R, et al. Characteristics of Streptococcus pneumoniae and atypical bacteria infections in children 2-5 years of age with community-acquired pneumonia. Clin Infect Dis 2002; 35:1345-52.
8. Kaplan EL, Johnson DR. Unexplained reduced microbiological efficacy of intramuscular benzathine penicillin G and of oral penicillin V in eradication of group A streptococci from children with acute pharyngitis. Pediatrics 2001; 108:1180-6.
9. Feigin RD, Cherry JD, eds. Textbook of pediatric infectious diseases. 4th ed. Philadelphia: W. B. Saunders, 1998.
10. Esposito S, Bosis S, Faelli N, et al. Role of atypical bacteria and azithromycin therapy in children with recurrent respiratory tract infections. Pediatr Infect Dis J 2005; 24:438-44.
11. Principi N, Esposito S, Cavagna R, et al. Recurrent respiratory tract infections in pediatric age: a population-based survey of the therapeutic role of macrolides. J Chemother 2003; 15:53-9.
12. Rios AM, Fonseca-Aten M, Mejias A, et al. Microbiologic and immunologic evaluation of a single high dose of azithromycin for treatment of experimental Mycoplasma pneumoniae pneumonia. Antimicrob Agents Chemother 2005; 49:3970-3.